AI Article Synopsis

  • The study examines the effectiveness and safety of arteriovenous fistulas in octogenarian patients undergoing hemodialysis, analyzing outcomes such as patency rates and survival over 24 months.
  • It involved a review of 88 interventions in 70 patients, finding a significant primary failure rate and various documented complications like edema and infection.
  • Results indicate that octogenarians have similar fistula patency rates as younger patients, suggesting age alone shouldn't prevent the use of arteriovenous fistulas in this population.

Article Abstract

Unlabelled: Introduction Guidelines have been recommending the use of arteriovenous fistula among the hemodialysis population, but no clear conclusion has emerged with regard to the adequate access type in octogenarians. In this paper, the outcomes of arteriovenous fistula in octogenarian cohort were presented for death-censored cumulative patency rate, complications, and patients' survival rate. Methods A retrospective review of 88 consecutive arteriovenous fistula interventions in 70 octogenarian patients were performed at one referral institution between January 2010 and June 2014. The patients' records were analyzed and postoperative complications were documented. Death-censored cumulative arteriovenous fistula patency rates were calculated, and Kaplan-Meier method was used to analyze patient survival for 24 months.

Findings: Eighty-eight arteriovenous fistula constructions and six salvage procedures were performed in 70 octogenarians. Fifty-four (61.3%) forearm and 34 (38.7%) upper arm fistulas were created. All types of fistulas had 6-, 12-, 18-, and 24-month death-censored cumulative patency rates of 63.6%, 58.3%, 48.8%, and 41.4%, respectively. The primary failure rate was 40.9%. A total of 15 complications were documented as edema, hematoma/bleeding, infection, distal ischemia, and venous aneurysm, all of which had been treated. Patient survival rates for 12 and 24 months were 68.5% and 58.5%, respectively.

Discussion And Conclusion: This analysis regarding arteriovenous fistula in octogenarian end-stage renal disease patients figured out equal death-censored cumulative patency compared to nonelderly, and two-year survival rate was acceptable. This study strengthens the argument that arteriovenous fistula should be the best proper choice in selected octogenarians; older age only should not be considered as an absolute contraindication for arteriovenous fistula creation in octogenarians; and patient-based approach should be applied.

Download full-text PDF

Source
http://dx.doi.org/10.1177/1708538118762067DOI Listing

Publication Analysis

Top Keywords

arteriovenous fistula
36
death-censored cumulative
16
cumulative patency
12
fistula
9
outcomes arteriovenous
8
fistula hemodialysis
8
arteriovenous
8
fistula octogenarian
8
survival rate
8
complications documented
8

Similar Publications

Introduction: Chronic hand ischaemia may affect some haemodialysis patients with an arteriovenous fistula (AVF) or graft (AVG), a condition known as haemodialysis access-induced distal ischaemia (HAIDI). Duplex ultrasonography (DUS) can provide comprehensive insights into anatomical and perfusion properties, and measuring the hand acceleration time (HAT) has been demonstrated to be sensitive within the framework of chronic upper limb ischaemia.

Methods And Analysis: This single-centre, prospective cohort study will involve adult end-stage renal disease (ESRD) patients requiring either AVF or AVG for haemodialysis.

View Article and Find Full Text PDF

Clinical Manifestations.

Alzheimers Dement

December 2024

Sanatorio de la Trinidad Mitre, Buenos Aires, Argentina.

Background: Dural arteriovenous fistulas (DAVFs) are abnormal communications between dural arteries and cortical, meningeal, or dural sinus veins. They represent 10-15% of intracranial arteriovenous malformations. In rare cases, they have been associated with potentially reversible cognitive impairment and dementia.

View Article and Find Full Text PDF

Introduction: The 2019 Kidney Disease Outcome Quality Initiative guidelines emphasize the importance of selecting dialysis based on the life expectancy of the patient. However, it is difficult to predict the life expectancy of a patient during arteriovenous fistula creation. We investigated whether neutrophil-to-lymphocyte, monocyte-to-lymphocyte, and platelet-to-lymphocyte ratios measured before dialysis could predict mortality.

View Article and Find Full Text PDF

Comparison of end-to-side and side-to-side anastomosis techniques in arteriovenous fistula for hemodialysis. A systematic review and meta-analysis.

Ann Vasc Surg

December 2024

Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal; Department of Angiology and Vascular Surgery, Centro Hospitalar de Trás os Montes e Alto Douro, Vila Real, Portugal.

Autogenous arteriovenous fistula (AVF) is the vascular access of choice for chronic kidney disease to patients requiring hemodialysis. However, there still needs to be more consensus on whether the best surgical approach is an end-of-vein to side-of-artery (ETS) or a side-of-vein to side-of-artery (STS) anastomosis. This study aims to compare venous maturation rates, mid-term patency and post-operative steal syndrome rates between ETS and STS techniques for arteriovenous fistulas.

View Article and Find Full Text PDF

Persistent trigeminal artery variant as a duplicate anterior inferior cerebellar artery.

Surg Radiol Anat

December 2024

Department of Neurosurgery, Nakamura Memorial Hospital, South 1, West 14, Chuo-ku, Sapporo, 060-8570, Hokkaido, Japan.

Purpose: A persistent trigeminal artery is the most common persistent carotid-vertebrobasilar anastomosis. Persistent trigeminal artery variants (PTAVs) terminate in the cerebellar arteries without connecting to the basilar artery; of these, the anterior inferior cerebellar artery (AICA) is the most common. AICA duplication is frequently observed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!